These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36753964)

  • 1. Cationic lipid-conjugated bis-arylidene oxindole derivatives as broad-spectrum breast cancer-selective therapeutics.
    Yousuf M; Sridharan K; Mishra T; Mahadik NS; Banerjee R; Adhikari SS
    Bioorg Chem; 2023 Apr; 133():106395. PubMed ID: 36753964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bis-arylidene oxindoles for colorectal cancer nanotherapy.
    Bhattacharyya T; Mishra T; Das D; Adhikari SS; Banerjee R
    Bioorg Chem; 2024 May; 146():107294. PubMed ID: 38507997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bis-arylidene oxindoles as anti-breast-cancer agents acting via the estrogen receptor.
    Pal A; Ganguly A; Ghosh A; Yousuf M; Rathore B; Banerjee R; Adhikari S
    ChemMedChem; 2014 Apr; 9(4):727-32. PubMed ID: 24482362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and Synthesis of New
    Farghaly TA; Pashameah RA; Bayazeed A; Al-Soliemy AM; Alsaedi AMR; Harras MF
    Med Chem; 2024; 20(1):63-77. PubMed ID: 37723960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA Fragmentation, Cell Cycle Arrest, and Docking Study of Novel Bis Spiro-cyclic 2-oxindole of Pyrimido[4,5-b]quinoline-4,6-dione Derivatives Against Breast Carcinoma.
    Mohamed MF; Abdelmoniem AM; Elwahy AHM; Abdelhamid IA
    Curr Cancer Drug Targets; 2018; 18(4):372-381. PubMed ID: 28669339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New cell cycle checkpoint pathways regulators with 2-Oxo-indoline scaffold as potential anticancer agents: Design, synthesis, biological activities and in silico studies.
    Abd El-Wahab HAA; Mansour HS; Ali AM; El-Awady R; Aboul-Fadl T
    Bioorg Chem; 2022 Mar; 120():105622. PubMed ID: 35091290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, Biological Evaluation and In Silico Studies of Certain Oxindole-Indole Conjugates as Anticancer CDK Inhibitors.
    Al-Warhi T; El Kerdawy AM; Aljaeed N; Ismael OE; Ayyad RR; Eldehna WM; Abdel-Aziz HA; Al-Ansary GH
    Molecules; 2020 Apr; 25(9):. PubMed ID: 32349307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Bioactivity Assessment of Novel Spiro Pyrazole-Oxindole Congeners Exhibiting Potent and Selective
    Abo-Salem HM; Nassrallah A; Soliman AAF; Ebied MS; Elawady ME; Abdelhamid SA; El-Sawy ER; Al-Sheikh YA; Aboul-Soud MAM
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32138244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of new estradiol-cationic lipid hybrids: ten-carbon twin chain cationic lipid is a more suitable partner for estradiol to elicit better anticancer activity.
    Sudhakar G; Bathula SR; Banerjee R
    Eur J Med Chem; 2014 Oct; 86():653-63. PubMed ID: 25222876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore based drug design and synthesis of oxindole bearing hybrid as anticancer agents.
    Pathak A; Pandey V; Raj Pokharel Y; Devaraji V; Ali A; Haider K; Saad S; Dewangan RP; Siddiqui N; Shahar Yar M
    Bioorg Chem; 2021 Nov; 116():105358. PubMed ID: 34544029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective CDK4/6 inhibition of novel 1,2,3-triazole tethered acridinedione derivatives induces G1/S cell cycle transition arrest via Rb phosphorylation blockade in breast cancer models.
    Praveenkumar E; Gurrapu N; Kolluri PK; Shivaraj ; Subhashini NJP; Dokala A
    Bioorg Chem; 2021 Nov; 116():105377. PubMed ID: 34670329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of enamino-2-oxindoles via conjugate addition between α-azido ketones and 3-alkenyl oxindoles: Cytotoxicity evaluation and apoptosis inducing studies.
    Kumar NP; Vanjari Y; Thatikonda S; Pooladanda V; Sharma P; Sridhar B; Godugu C; Kamal A; Shankaraiah N
    Bioorg Med Chem Lett; 2018 Dec; 28(22):3564-3573. PubMed ID: 30318440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic block amphiphiles show anti-mitochondrial activity in multi-drug resistant breast cancer cells.
    Czupiel PP; Delplace V; Shoichet MS
    J Control Release; 2019 Jul; 305():210-219. PubMed ID: 31071370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting tyrosine kinase: Development of acridone - pyrrole - oxindole hybrids against human breast cancer.
    Kaur M; Singh P
    Bioorg Med Chem Lett; 2019 Jan; 29(1):32-35. PubMed ID: 30446310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of substituted biphenyl methylene indolinones as apoptosis inducers and tubulin polymerization inhibitors.
    Donthiboina K; Anchi P; Sri Ramya PV; Karri S; Srinivasulu G; Godugu C; Shankaraiah N; Kamal A
    Bioorg Chem; 2019 May; 86():210-223. PubMed ID: 30716619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spiro-oxindoles as a Promising Class of Small Molecule Inhibitors of p53-MDM2 Interaction Useful in Targeted Cancer Therapy.
    Gupta AK; Bharadwaj M; Kumar A; Mehrotra R
    Top Curr Chem (Cham); 2017 Feb; 375(1):3. PubMed ID: 27943171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Synthesis of DNA-Interactive β-Carboline-Oxindole Hybrids as Cytotoxic and Apoptosis-Inducing Agents.
    Tokala R; Thatikonda S; Vanteddu US; Sana S; Godugu C; Shankaraiah N
    ChemMedChem; 2018 Sep; 13(18):1909-1922. PubMed ID: 30010248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-drug nanoparticle induces synergistic treatment efficacies in HER2 positive breast cancer cells.
    Abedin MR; Powers K; Aiardo R; Barua D; Barua S
    Sci Rep; 2021 Apr; 11(1):7347. PubMed ID: 33795712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methoxy-enriched cationic stilbenes as anticancer therapeutics.
    Yousuf M; Jinka S; Adhikari SS; Banerjee R
    Bioorg Chem; 2020 May; 98():103719. PubMed ID: 32171988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfonamide metformin derivatives induce mitochondrial-associated apoptosis and cell cycle arrest in breast cancer cells.
    Markowicz-Piasecka M; Huttunen J; Zajda A; Sikora J; Huttunen KM
    Chem Biol Interact; 2022 Jan; 352():109795. PubMed ID: 34953865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.